Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results.

Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS (2014) 1.67

Repeat HIV-testing is associated with an increase in behavioral risk among men who have sex with men: a cohort study. BMC Med (2015) 1.34

Using HIV networks to inform real time prevention interventions. PLoS One (2014) 1.29

Development and validation of the San Diego Early Test Score to predict acute and early HIV infection risk in men who have sex with men. Clin Infect Dis (2015) 1.28

Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States. J Infect Dis (2013) 1.13

Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men. J Acquir Immune Defic Syndr (2016) 1.07

Risk Factors for Acute and Early HIV Infection Among Men Who Have Sex With Men (MSM) in San Diego, 2008 to 2014: A Cohort Study. Medicine (Baltimore) (2015) 1.05

Factors associated with intention to use internet-based testing for sexually transmitted infections among men who have sex with men. J Med Internet Res (2013) 1.02

Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release. J Virol (2014) 0.91

Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California. J Infect Dis (2012) 0.90

HIV Transmission Networks in the San Diego-Tijuana Border Region. EBioMedicine (2015) 0.90

HIV Infection Rates and Risk Behavior among Young Men undergoing community-based Testing in San Diego. Sci Rep (2016) 0.89

Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection. J Clin Microbiol (2012) 0.89

Risk Behavior and Sexually Transmitted Infections Among Transgender Women and Men Undergoing Community-Based Screening for Acute and Early HIV Infection in San Diego. Medicine (Baltimore) (2015) 0.83

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology (2012) 0.81

Partner services in adults with acute and early HIV infection, San Diego, 1996-2014. AIDS (2016) 0.80

Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013. J Acquir Immune Defic Syndr (2016) 0.78

Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California. Clin Infect Dis (2016) 0.78

Seminal Shedding of CMV and HIV Transmission among Men Who Have Sex with Men. Int J Environ Res Public Health (2015) 0.78

Evaluation of pooled rapid HIV antibody screening of patients admitted to a San Diego Hospital. J Virol Methods (2011) 0.77

Summaries for patients. HIV nucleic acid testing program with automated Internet and voicemail systems. Ann Intern Med (2010) 0.75

A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemics. Sci Rep (2016) 0.75

Early Antiretroviral Therapy is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations. PLoS Pathog (2017) 0.75

Evaluation of the Predictive Potential of the Short Acute Retroviral Syndrome Severity Score for HIV-1 Disease Progression in Individuals With Acute HIV Infection. J Acquir Immune Defic Syndr (2017) 0.75

Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits. J Neurovirol (2013) 0.75

Concurrency and HIV transmission network characteristics among MSM with recent HIV infection. AIDS (2016) 0.75

Two additional implications of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med (2010) 0.75

Risk profile and HIV testing outcomes of women undergoing community-based testing in San Diego 2008-2014. Sci Rep (2017) 0.75

Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles. AIDS (2017) 0.75

No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men. J Virol (2017) 0.75

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28

Estimation of HIV incidence in the United States. JAMA (2008) 21.27

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08

Use of the Internet and e-mail for health care information: results from a national survey. JAMA (2003) 16.11

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66

Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med (2004) 5.78

The Internet as a newly emerging risk environment for sexually transmitted diseases. JAMA (2000) 5.38

Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS (2006) 3.70

Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988-2007. Prev Med (2008) 3.60

Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS (2005) 3.40

Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr (2003) 3.14

Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA (2002) 2.94

Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44

HIV testing in a high-incidence population: is antibody testing alone good enough? Clin Infect Dis (2009) 2.23

Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol (2009) 2.18

Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr (2006) 2.15

Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project. J Acquir Immune Defic Syndr (2005) 1.85

Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care (2003) 1.78

Internet use among people living with HIV/AIDS: coping and health-related correlates. AIDS Patient Care STDS (2005) 1.74

Barebacking, the Internet, and harm reduction: an intercept survey with gay and bisexual men in Los Angeles and New York City. AIDS Behav (2007) 1.72

HIV prevalence and sexual risk behaviors among men who have sex with men: results from a statewide population-based survey in California. J Acquir Immune Defic Syndr (2006) 1.61

Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. J Acquir Immune Defic Syndr (2005) 1.56

Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr (2009) 1.46

The process of seeking sex partners online and implications for STD/HIV prevention. AIDS Care (2004) 1.45

Internet-based health promotion and disease control in the 8 cities: successes, barriers, and future plans. Sex Transm Dis (2005) 1.41

Outcomes of blood and oral fluid rapid HIV testing: a literature review, 2000-2006. AIDS Patient Care STDS (2007) 1.41

Routine detection of acute HIV infection through RNA pooling: survey of current practice in the United States. Sex Transm Dis (2007) 1.36

Failure to return for HIV posttest counseling in an STD clinic population. AIDS Educ Prev (2003) 1.26

Health information Websites: characteristics of US users by race and ethnicity. J Telemed Telecare (2007) 1.26

Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: a study of rapid versus standard testing. AIDS Patient Care STDS (2005) 1.15

Anonymous HIV testing with participant-controlled access to results using handheld computers: a new model of HIV testing used in a household survey in rural South Africa. Sex Transm Dis (2008) 0.93

Methamphetamine use and HIV symptom self-management. J Assoc Nurses AIDS Care (2006) 0.92

Internet partner notification: another arrow in the quiver. Sex Transm Dis (2008) 0.92

STI prevention services online: moving beyond the proof of concept. Sex Transm Dis (2008) 0.87

The risk of a second diagnostic window with 4th generation HIV assays: Two cases. J Clin Virol (2009) 0.86

Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A (2003) 12.75

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA (2008) 11.72

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med (2002) 10.03

Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med (2002) 9.70

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA (2010) 9.26

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA (2012) 8.94

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA (2006) 7.49

Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet (2012) 7.01

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet (2005) 5.75

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA (2002) 5.56

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis (2008) 5.20

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis (2003) 4.51

Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. J Virol (2007) 4.45

Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med (2013) 4.26

Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20

Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog (2013) 4.05

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A (2005) 3.94

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis (2005) 3.93

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA (2004) 3.74

Update of the drug resistance mutations in HIV-1: Spring 2008. Top HIV Med (2008) 3.66

2011 update of the drug resistance mutations in HIV-1. Top Antivir Med (2011) 3.66

Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med (2013) 3.58

Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One (2013) 3.53

Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med (2009) 3.52

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol (2003) 3.29

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol (2004) 3.20

Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med (2006) 3.06

Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol (2008) 3.04

Update of the Drug Resistance Mutations in HIV-1. Top HIV Med (2008) 2.91

Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med (2010) 2.91

Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J Virol (2005) 2.83

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis (2013) 2.82

Update of the drug resistance mutations in HIV-1: 2007. Top HIV Med (2007) 2.79

Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep (2007) 2.69

Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis (2003) 2.54

Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol (2006) 2.48

Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health (2006) 2.42

Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J Virol (2006) 2.33

Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J Infect Dis (2006) 2.26

HIV superinfection. J Infect Dis (2005) 2.20

Whither or wither microbicides? Science (2008) 2.17

Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy (2008) 2.15

Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet (2013) 2.11

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis (2008) 2.08

Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology (2006) 2.07

Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. AIDS (2003) 2.05

Update of the drug resistance mutations in HIV-1: Fall 2005. Top HIV Med (2005) 2.04

Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep (2007) 2.04

Role of seminal shedding of herpesviruses in HIV Type 1 Transmission. J Infect Dis (2012) 1.99

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One (2012) 1.93

Incidence of HIV superinfection following primary infection. JAMA (2004) 1.92

Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis (2008) 1.86

Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (2002) 1.83

A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther (2002) 1.83

A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS (2009) 1.81

Serosorting can potentially increase HIV transmissions. AIDS (2007) 1.78

Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol (2005) 1.77

The origins of sexually transmitted HIV among men who have sex with men. Sci Transl Med (2010) 1.76

Tuberculosis and illicit drug use: review and update. Clin Infect Dis (2009) 1.76

Transmission behaviors of recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr (2006) 1.73

Drug resistance mutations in HIV-1. Top HIV Med (2003) 1.72

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology (2007) 1.72

Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis (2010) 1.71

Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antivir Ther (2012) 1.71

The need for treatment interruption studies and biomarker identification in the search for an HIV cure. AIDS (2015) 1.68

The global transmission network of HIV-1. J Infect Dis (2013) 1.68

Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection. J Acquir Immune Defic Syndr (2006) 1.66

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol (2013) 1.66

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. Top HIV Med (2006) 1.65

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis (2007) 1.64

Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health (2004) 1.62

Update of the drug resistance mutations in HIV-1: 2004. Top HIV Med (2004) 1.62

HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med (2004) 1.60

Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain (2006) 1.60